These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37507074)

  • 1. Germline Determinants of Esophageal Adenocarcinoma.
    Lee M; Eng G; Handte-Reinecker A; ; Deshpande VS; Yilmaz OH; Gala MK
    Gastroenterology; 2023 Nov; 165(5):1276-1279.e7. PubMed ID: 37507074
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeted Single Gene Mutation in Esophageal Adenocarcinoma.
    Lee KTW; Smith RA; Gopalan V; Lam AK
    Methods Mol Biol; 2018; 1756():213-229. PubMed ID: 29600373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and Quantification of MicroRNAs in Esophageal Adenocarcinoma.
    Amin M; Islam F; Gopalan V; Lam AK
    Methods Mol Biol; 2018; 1756():257-268. PubMed ID: 29600376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adenocarcinoma arising in gastroesophageal junction: a reappraisal].
    Zhang XH
    Zhonghua Bing Li Xue Za Zhi; 2007 Jun; 36(6):363-5. PubMed ID: 17822618
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor microRNA-126 controls cell viability and associates with poor survival in patients with esophageal adenocarcinoma.
    Toxopeus E; Lynam-Lennon N; Biermann K; Dickens G; de Ruiter PE; van Lanschot J; Reynolds JV; Wijnhoven B; O'Sullivan J; van der Laan L
    Exp Biol Med (Maywood); 2019 Oct; 244(14):1210-1219. PubMed ID: 31390899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Genome Sequencing in Esophageal Adenocarcinoma.
    Pillai S; Gopalan V; Lam AK
    Methods Mol Biol; 2018; 1756():231-246. PubMed ID: 29600374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal cancer in a family with hamartomatous tumors and germline PTEN frameshift and SMAD7 missense mutations.
    Sherman SK; Maxwell JE; Qian Q; Bellizzi AM; Braun TA; Iannettoni MD; Darbro BW; Howe JR
    Cancer Genet; 2015; 208(1-2):41-6. PubMed ID: 25554686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Defect in Submucosal Gland-Associated Caveolin-3: A New Paradigm in Esophageal Adenocarcinoma Risk.
    Garman KS; Purkayastha BPD; Hogue JA; Fecteau R; ; Guda K; Chak A
    Gastroenterology; 2023 Dec; 165(6):1561-1564.e3. PubMed ID: 37659676
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutational subgroups for oesophageal adenocarcinoma.
    Burki TK
    Lancet Oncol; 2016 Oct; 17(10):e426. PubMed ID: 27641478
    [No Abstract]   [Full Text] [Related]  

  • 10. Submucosal gland adenocarcinoma of the esophagus. A rare non-Barrett's associated tumor.
    Saez de Gordoa K; Guerrero J; Bishop R; Archilla I; Rodrigo M; Sendino O; Momblan D; Sauri T; Jares P; Cuatrecasas M
    Gastroenterol Hepatol; 2021 May; 44(5):367-369. PubMed ID: 33187748
    [No Abstract]   [Full Text] [Related]  

  • 11. IL-1 RN polymorphism is not associated with Barrett's esophagus and esophageal adenocarcinoma.
    Moons LM; Siersema PD; Kuipers EJ; van Vliet AH; Kusters JG
    Am J Gastroenterol; 2005 Dec; 100(12):2818. PubMed ID: 16393246
    [No Abstract]   [Full Text] [Related]  

  • 12. Genome-Scale Analysis Identifies Novel Transcript-Variants in Esophageal Adenocarcinoma.
    Purkayastha BPD; Chan ER; Ravillah D; Ravi L; Gupta R; Canto MI; Wang JS; Shaheen NJ; Willis JE; Chak A; Varadan V; Guda K
    Cell Mol Gastroenterol Hepatol; 2020; 10(3):652-654.e17. PubMed ID: 32344180
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma.
    Fitzgerald RC
    Gut; 2006 Dec; 55(12):1810-20. PubMed ID: 17124160
    [No Abstract]   [Full Text] [Related]  

  • 14. Esophageal squamous cell carcinoma and adenocarcinoma: At the Gates of Mordor.
    Lin J
    J Thorac Cardiovasc Surg; 2017 Oct; 154(4):1444-1445. PubMed ID: 28918927
    [No Abstract]   [Full Text] [Related]  

  • 15. Somatic DNA Copy-Number Alterations Detection for Esophageal Adenocarcinoma Using Digital Polymerase Chain Reaction.
    Lee KTW; Gopalan V; Lam AK
    Methods Mol Biol; 2018; 1756():195-212. PubMed ID: 29600372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
    Whitson MJ; Falk GW
    Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular origins and molecular mechanisms of Barrett's esophagus and esophageal adenocarcinoma.
    Fang Y; Chen X; Bajpai M; Verma A; Das KM; Souza RF; Garman KS; Donohoe CL; O'Farrell NJ; Reynolds JV; Dvorak K
    Ann N Y Acad Sci; 2013 Oct; 1300():187-199. PubMed ID: 24117642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definitions of oesophageal cancer.
    Burki TK
    Lancet Oncol; 2017 Feb; 18(2):e71. PubMed ID: 28089633
    [No Abstract]   [Full Text] [Related]  

  • 19. Vacutainers and Primers Over X-Rays and Gamma Rays: The Role of Circulating Tumor DNA in Esophageal Adenocarcinoma Staging and Surveillance: Invited Commentary on "Potential Clinical Utility of a Targeted Circulating Tumor DNA Assay in Esophageal Adenocarcinoma".
    Chandra R; Reznik SI
    Ann Surg; 2022 Aug; 276(2):e127-e128. PubMed ID: 36036995
    [No Abstract]   [Full Text] [Related]  

  • 20. Neoplastic risk assessment in Barrett's esophagus: How far have we come?
    Noffsinger A
    Hum Pathol; 2003 Oct; 34(10):965-7. PubMed ID: 14608528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.